Navigation Links
Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results
Date:9/17/2009

====== ====== * Marketable securities $1,792 $4,495 ===== ===== Pharmacyclics, Inc. (a development stage enterprise) Reconciliation of selected GAAP measures to non-GAAP measures Fiscal Fourth Quarter 2009 (unaudited) (in thousands) Three Months Ended June 30 2009 Reconciliation of selected GAAP measures to non-GAAP measures (1) Fiscal Q4 Fiscal Q4 2009 2008 ------- ------- NET LOSS per GAAP ($5,406) ($4,628) ------- ------- Adjustments R&D share-based compensation (2) 186 210 G&A share-based compensation (2) 186 248 Interest Adjustment for RWD loan (3) 299 - Provision for Income Tax (4) 550 - ------ ------ 1,221 458 ------- ------- NET LOSS per non-GAAP ($4,185) ($4,170) ------- ------- (1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP. See also "Use of non-GAAP Financial Measures" in this press release. (2) All share-based compensation was excluded from the non-GAAP Analysis. (3) Due to the below
'/>"/>
SOURCE Pharmacyclics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Pharmacyclics Sets Record Date for Rights Offering
2. Pharmacyclics Reports Third Quarter Fiscal 2009 Financial Results
3. Pharmacyclics Announces Dr. Ahmed Hamdy as New Chief Medical Officer
4. Pharmacyclics Receives Nasdaq Notification
5. Pharmacyclics Files Schedule 14D-9 Statement with Securities and Exchange Commission
6. Pharmacyclics Reports Third Quarter 2008 Financial Results
7. Pharmacyclics Announces Conference Call to Discuss Third Quarter 2008 Financial Results
8. Pharmacyclics Announces Conference Call to Discuss Second Quarter 2008 Financial Results
9. Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
10. J.D. Power and Associates Reports: Among Pharmacy Customers, Satisfaction is Equally as High for the Privately Insured and for Those With Public-Private Insurance
11. Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Deer Path of Huntley -- a BMA affordable assisted ... 3 p.m. to 4 p.m. on Feb. 13. , The community, ... adults with physical disabilities between the ages of 22 and 64. ... and sweetheart-themed karaoke. , For more information about the event or ...
(Date:1/22/2015)... 22, 2015 The City of West Hollywood hosted ... to commemorate the 42nd anniversary of the Supreme Court decision Roe ... been 42 years since the Roe vs. Wade decision and the ... present as ever,” said City of West Hollywood Councilmember Abbe Land. ...
(Date:1/22/2015)... 2015 VogueQueen is a seasoned and trusted ... many designers are thrilled to have it lead the wedding ... new collection of prom dresses for the global market. , ... strategic vision and he focuses on continuing the goal of ...
(Date:1/22/2015)... 23, 2015 AngelWeddingDress, the premier women’s ... maternity wedding dresses. View website of AngelWeddingDress.com ... for maternity wedding dresses online for a bridal party. ... high quality for them. Its maternity wedding dresses are ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo ... the federal multidistrict litigation underway in U.S. District Court, ... an Order dated January 20th, the Court has remanded ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4
... Inc. (Nasdaq: CRTX ) announced today that it ... 27, 2009. At the special meeting of stockholders, Cornerstone,s ... sale of shares of Cornerstone,s common stock to Chiesi Farmaceutici ... May 6, 2009, between Cornerstone and Chiesi Farmaceutici SpA. , ...
... June 11 The Campaign for Tobacco-Free Kids applauds U.S. Senator ... gives the U.S. Food and Drug Administration (FDA) authority to ... tobacco marketing and sales to kids. The U.S. Senate ... has approved similar legislation, and Congress is expected to quickly ...
... 11 The Campaign for Tobacco-Free Kids applauds U.S. Senators ... historic legislation that gives the U.S. Food and Drug Administration ... crack down on tobacco marketing and sales to kids. ... The House has approved similar legislation, and Congress is ...
... Tobacco-Free Kids applauds U.S. Senator Bill Nelson for voting today ... Drug Administration (FDA) authority to regulate tobacco products, including the ... kids. The U.S. Senate approved the bipartisan bill 79 ... Congress is expected to quickly send a final bill to ...
... Tobacco-Free Kids applauds U.S. Senator Sherrod Brown for leading the ... gives the U.S. Food and Drug Administration (FDA) authority to ... tobacco marketing and sales to kids. The U.S. Senate ... House has approved similar legislation, and Congress is expected to ...
... , June 11 The Campaign for Tobacco-Free Kids ... today to approve historic legislation that gives the U.S. Food ... the authority to crack down on tobacco marketing and sales ... 79 to 17. The House has approved similar legislation, ...
Cached Medicine News:Health News:Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Issuance and Sale of Stock 2Health News:Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Issuance and Sale of Stock 3Health News:Senator McCaskill Votes to Protect America's Kids From Tobacco 2Health News:Senators Carper and Kaufman Vote to Protect America's Kids From Tobacco 2Health News:Senator Bill Nelson Votes to Protect America's Kids from Tobacco 2Health News:Senator Brown Leads Fight to Protect America's Kids from Tobacco 2Health News:Senators Mikulski and Cardin Vote to Protect America's Kids From Tobacco 2
(Date:1/22/2015)... 22, 2015  ViewRay™, a privately held medical device company, ... distributor agreement with ITOCHU Corporation (Tokyo Stock Exchange TYO: ... the treatment of cancer in Japan ... world,s first and only MRI-guided radiation therapy system that ...
(Date:1/22/2015)...  Uroplasty, Inc. (NASDAQ: UPI ), a medical device ... to treat voiding dysfunctions, today reported financial results for ... Global revenue for the Company,s Urgent ®  PC ... quarterly revenue record, as compared to $3.9 million in ...
(Date:1/22/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the ... therapies for cardiovascular disease and overall health is pleased to ... 2014 and its outlook for 2015 from the CEO, Mr. ... We would like to take this opportunity to share ...
Breaking Medicine Technology:ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... , , , , ... WX ), a,leading pharmaceutical, biotechnology, and medical-device research ... announced that it had been selected for the Deloitte Technology ... to receive this award,for the past six years. The Deloitte ...
... Pa., Dec. 21 West Pharmaceutical Services, Inc. (NYSE: ... unanimously decided on December 15, 2009, to ask shareholders to ... starting in 2012. Currently, the Company,s board has three classes ... term. The proposed amendment will not shorten the current ...
Cached Medicine Technology:West Announces Intention to Elect Entire Board Annually 2
... The SpectraMax 190 spectrophotometer is ideal for ... For aqueous solutions, our patented* PathCheck sensor ... in each microplate well, and normalizes the ... corrected absorbance is within 5% of the ...
The Clearblue Easy Ovulation Test detects the surge of "luteinizing hormone in your urine, which usually happens 24 to 36 hours before you ovulate (release an egg). That means youll know the 2 best ...
... In the fast-paced world of echo ... make a real difference in your ability ... developed Xcelera Echo Lab Management, a unique ... providing the tools your department needs to ...
These products are primarily for use with paediatric patients and for patients with difficult veins....
Medicine Products: